Sign in Pull a receipt

RCKT

ROCKET PHARMACEUTICALS, INC.

Biotechnology · Biotechnology

$116.23 sample

-1.55 (-1.32%) 1D

Market cap

$549.6B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-30

Alerts

8

Price$116.23 +14.98% 3M daily closessample

123.1999.37

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: Chief Executive Officer
Oct 14INSInsider sell: General Counsel
Oct 06INSInsider sell: Chief Executive Officer
Sep 30SEC8-K filed: material event
Sep 22INSInsider buy: General Counsel
Sep 15INSInsider sell: General Counsel
Sep 07SECForm 144 filed
Aug 28INSInsider sell: Chief Executive Officer

Sign up to see the real RCKT record →

Company facts

SEC EDGAR registration

Name: ROCKET PHARMACEUTICALS, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +23sample, -100 to +100
Reporting currency: USD

Who is positioning in RCKT

sample

Insiders: 34 insider transactions over 90 days, net selling, $313.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 29 funds hold $10.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.2B +19.0% y/y

Q4 2024Q3 2026

Inventory$11.2B +3.4% y/y

Q4 2024Q3 2026

Accounts receivable$9.1B +22.1% y/y

Q4 2024Q3 2026

Total debt$22.8B +14.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $445.3B -7.9% 3M
Sample peer B: $391.8B +3.0% 3M
Sample peer C: $454.7B +7.2% 3M
Sample peer D: $132.6B +7.4% 3M
Sample peer E: $174.5B +6.7% 3M